Walleye Capital LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 74 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$37,000
-53.2%
32,875
-39.5%
0.00%
-50.0%
Q4 2021$79,000
+107.9%
54,365
+331.2%
0.00%
+100.0%
Q3 2021$38,000
-82.2%
12,607
-72.5%
0.00%
-85.7%
Q2 2021$213,000
+34.0%
45,845
-0.5%
0.01%
-61.1%
Q3 2020$159,000
+29.3%
46,095
+170.4%
0.02%
+125.0%
Q4 2019$123,00017,0440.01%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders